Utilize este identificador para referenciar este registo:
https://hdl.handle.net/10316/107455
Título: | DARK Classics in Chemical Neuroscience: Bucinnazine | Autor: | Resnik, Karissa Brandão, Pedro Alves, Emanuele Amorim |
Palavras-chave: | New synthetic opioids; bucinnazine; AP-237; toxicology | Data: | 6-Out-2021 | Editora: | ACS American Chemical Society | Título da revista, periódico, livro ou evento: | Chemical Neuroscience | Volume: | 12 | Número: | 19 | Resumo: | Bucinnazine (1-butyryl-4-cinnamylpiperazine) is a synthetic opioid recently discovered in heroin seized samples in the U.S and in Europe. It was first synthesized in the late 1960s and has been used for the treatment of cancer-associated chronic pain in China for many years. Bucinnazine is one of the most potent compounds among the series of piperazines, which also include other relevant compounds, such as MT-45, AD-1211, and 2-methyl-AP-237, a methylated derivative of bucinnazine. Bucinnazine is considered a μ-selective opioid, binding primarily to the μ-opioid receptor. However, bucinnazine also may share several characteristics with other piperazines, which act primarily on dopamine, serotonin, and norepinephrine neurotransmission. At the present, bucinnazine is not scheduled in the U.S., as it is not a therapeutic choice for the treatment of pain. Nevertheless, with the advent of the cryptocurrency and the easy access of substances on the Darknet, bucinnazine is a real threat to the public health. This review discusses the main aspects of bucinnazine's chemistry, pharmacology, and toxicology and brings attention to the risk of the presence of this opioid in seized samples. Further studies on bucinnazine are still required to better evaluate its toxicity mechanisms, potential for drug-drug interactions, and abuse liability. Such information will be of utmost importance to guide future policies concerning the legal status of bucinnazine in the U.S. | URI: | https://hdl.handle.net/10316/107455 | ISSN: | 1948-7193 1948-7193 |
DOI: | 10.1021/acschemneuro.1c00522 | Direitos: | embargoedAccess |
Aparece nas coleções: | I&D CQC - Artigos em Revistas Internacionais |
Ficheiros deste registo:
Ficheiro | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Resnik2021ACSChemNeuro.pdf | 385.69 kB | Adobe PDF | Ver/Abrir |
Citações SCOPUSTM
11
Visto em 1/jul/2024
Citações WEB OF SCIENCETM
10
Visto em 2/jul/2024
Visualizações de página
64
Visto em 16/jul/2024
Downloads
387
Visto em 16/jul/2024
Google ScholarTM
Verificar
Altmetric
Altmetric
Este registo está protegido por Licença Creative Commons